Literature DB >> 27443356

Neurodevelopmental Disorders or Early Death in Siblings of Children With Cerebral Palsy.

Mette C Tollånes1, Allen J Wilcox2, Camilla Stoltenberg3, Rolv T Lie3, Dag Moster4.   

Abstract

OBJECTIVES: To explore the presence of shared underlying causes of cerebral palsy (CP) and other neurodevelopmental disorders, by examining risks of other disorders in siblings of children with CP.
METHODS: We used Norwegian national registries to identify 1.4 million pairs of full siblings (singletons) and 28 000 sets of twins born from 1967 to 2006, identify stillbirths and neonatal deaths, and find individuals with CP, epilepsy, intellectual disability, autism spectrum disorders, attention-deficit/hyperactivity disorder, blindness, deafness, schizophrenia, and bipolar disorder. Associations between CP in 1 sibling and neurodevelopmental disorders or early death in other siblings were estimated using logistic regression models.
RESULTS: There were 5707 neonatal survivors (beyond 28 days) with CP (2.5/1000). These children had substantial comorbidity (eg, 29% had epilepsy). Singleton siblings of (singleton) children with CP had increased risks of neurodevelopmental problems, including epilepsy (odds ratio [OR], 1.8 [95% confidence interval (CI), 1.5-2.5]), intellectual disability (OR, 2.3 [95% CI, 1.8-2.9]), autism spectrum disorders (OR, 1.6 [95% CI, 1.1-2.2]), attention-deficit/hyperactivity disorder (OR 1.3 [95% CI, 1.1-1.6]), blindness (OR 2.4 [95% CI, 1.1-5.4]), and schizophrenia (OR 2.0 [95% CI, 1.2-3.2]). There was no increase in risk of bipolar disorder (OR 1.0 [95% CI, 0.6-1.6]). Families with children with CP also had increased risk of losing another child in the perinatal period (stillbirth OR, 1.8 [95% CI, 1.5- 2.3]; neonatal death OR, 1.7 [95% CI, 1.3-2.2]). Associations were stronger within sets of twins.
CONCLUSIONS: Siblings of a child with CP were at increased risk for a variety of other neurodevelopmental morbidities, as well as early death, indicating the presence of shared underlying causes.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2016        PMID: 27443356      PMCID: PMC4960730          DOI: 10.1542/peds.2016-0269

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  Prevalence and characteristics of children with cerebral palsy in Europe.

Authors: 
Journal:  Dev Med Child Neurol       Date:  2002-09       Impact factor: 5.449

Review 2.  Prenatal Factors in Singletons with Cerebral Palsy Born at or near Term.

Authors:  Karin B Nelson; Eve Blair
Journal:  N Engl J Med       Date:  2015-09-03       Impact factor: 91.245

3.  Birth Prevalence of Cerebral Palsy: A Population-Based Study.

Authors:  Kim Van Naarden Braun; Nancy Doernberg; Laura Schieve; Deborah Christensen; Alyson Goodman; Marshalyn Yeargin-Allsopp
Journal:  Pediatrics       Date:  2015-12-09       Impact factor: 7.124

Review 4.  The diverse genetic landscape of neurodevelopmental disorders.

Authors:  Wen F Hu; Maria H Chahrour; Christopher A Walsh
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

Review 5.  Recent challenges to the psychiatric diagnostic nosology: a focus on the genetics and genomics of neurodevelopmental disorders.

Authors:  Young Shin Kim; Matthew W State
Journal:  Int J Epidemiol       Date:  2014-03-11       Impact factor: 7.196

6.  The association of Apgar score with subsequent death and cerebral palsy: A population-based study in term infants.

Authors:  D Moster; R T Lie; L M Irgens; T Bjerkedal; T Markestad
Journal:  J Pediatr       Date:  2001-06       Impact factor: 4.406

7.  Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in Norwegian children.

Authors:  Pål Surén; Inger Johanne Bakken; Heidi Aase; Richard Chin; Nina Gunnes; Kari Kveim Lie; Per Magnus; Ted Reichborn-Kjennerud; Synnve Schjølberg; Anne-Siri Øyen; Camilla Stoltenberg
Journal:  Pediatrics       Date:  2012-06-18       Impact factor: 7.124

8.  Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: a national cohort study.

Authors:  Håvard Trønnes; Allen J Wilcox; Rolv T Lie; Trond Markestad; Dag Moster
Journal:  Dev Med Child Neurol       Date:  2014-03-13       Impact factor: 5.449

Review 9.  Environmental factors associated with a spectrum of neurodevelopmental deficits.

Authors:  Pauline Mendola; Sherry G Selevan; Suzanne Gutter; Deborah Rice
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

10.  Clinically relevant copy number variations detected in cerebral palsy.

Authors:  Maryam Oskoui; Matthew J Gazzellone; Bhooma Thiruvahindrapuram; Mehdi Zarrei; John Andersen; John Wei; Zhuozhi Wang; Richard F Wintle; Christian R Marshall; Ronald D Cohn; Rosanna Weksberg; Dimitri J Stavropoulos; Darcy Fehlings; Michael I Shevell; Stephen W Scherer
Journal:  Nat Commun       Date:  2015-08-03       Impact factor: 14.919

View more
  4 in total

Review 1.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

2.  Parental socioeconomic status and risk of cerebral palsy in the child: evidence from two Nordic population-based cohorts.

Authors:  Ingeborg Forthun; Katrine Strandberg-Larsen; Allen J Wilcox; Dag Moster; Tanja Gram Petersen; Torstein Vik; Rolv Terje Lie; Peter Uldall; Mette Christophersen Tollånes
Journal:  Int J Epidemiol       Date:  2018-08-01       Impact factor: 7.196

3.  Adverse motor outcome after paediatric ischaemic stroke: A nationwide cohort study.

Authors:  Katarina Svensson; Anna Walås; Jenny Bolk; Peter Bang; Heléne E K Sundelin
Journal:  Paediatr Perinat Epidemiol       Date:  2022-02-16       Impact factor: 3.103

4.  Cryptorchidism in Boys With Cerebral Palsy Is Associated With the Severity of Disease and With Co-Occurrence of Other Congenital Anomalies.

Authors:  Julia Spencer Barthold; Anton Wintner; Jennifer A Hagerty; Kenneth J Rogers; Md Jobayer Hossain
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-16       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.